BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31492753)

  • 1. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
    Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
    J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma.
    Li C; Zheng H; Hou W; Bao H; Xiong J; Che W; Gu Y; Sun H; Liang P
    Cell Death Dis; 2019 Sep; 10(10):717. PubMed ID: 31558707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial-mesenchymal transition pathway in breast cancer.
    Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study.
    Nalla LV; Gondaliya P; Kalia K; Khairnar A
    Mol Biol Rep; 2022 Jul; 49(7):6987-6996. PubMed ID: 35486287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer.
    Lee JW; Guan W; Han S; Hong DK; Kim LS; Kim H
    Cancer Sci; 2018 May; 109(5):1404-1413. PubMed ID: 29575368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer.
    Yousefi A; Sotoodehnejadnematalahi F; Nafissi N; Zeinali S; Azizi M
    Sci Rep; 2024 Mar; 14(1):5845. PubMed ID: 38462658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
    Langer EM; Kendsersky ND; Daniel CJ; Kuziel GM; Pelz C; Murphy KM; Capecchi MR; Sears RC
    Oncogene; 2018 Feb; 37(8):1005-1019. PubMed ID: 29084210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.
    Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T
    J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200a-3p regulates epithelial-mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38 pathway.
    Wu Y; Sun K; Tu Y; Li P; Hao D; Yu P; Chen A; Wan Y; Shi L
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):41-56. PubMed ID: 37318032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA; Parvani JG; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axis.
    Xie H; Chen J; Ma Z; Gao Y; Zeng J; Chen Y; Yang Z; Xu S
    Prostate; 2024 Mar; 84(4):317-328. PubMed ID: 38145367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
    Fang Y; Zhang Q; Chen Z; Guo C; Wu J
    Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis.
    Perez-Oquendo M; Manshouri R; Tian Y; Fradette JJ; Rodriguez BL; Kundu ST; Gibbons DL
    Mol Cancer Res; 2023 Aug; 21(8):779-794. PubMed ID: 37255406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
    Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA
    Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-200-Zeb1 axis regulates key aspects of β-cell function and survival in vivo.
    Title AC; Silva PN; Godbersen S; Hasenöhrl L; Stoffel M
    Mol Metab; 2021 Nov; 53():101267. PubMed ID: 34116231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor GATA3 positively regulates NRP1 to promote radiation-induced pulmonary fibrosis.
    Yi J; Gao H; Wei X; Wang M; Xu W; Yu D; Zhao M; Zhao M; Wang Z; Wei W; Jin S
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130052. PubMed ID: 38342257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53/ZEB1-PLD3 feedback loop regulates cell proliferation in breast cancer.
    Liu BW; Sun N; Lin H; Zhou XJ; Ma HY; Wang X; Cao XC; Yu Y
    Cell Death Dis; 2023 Nov; 14(11):751. PubMed ID: 37978168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer.
    Miyazono K
    Proc Jpn Acad Ser B Phys Biol Sci; 2009; 85(8):314-23. PubMed ID: 19838011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-409-3p targets a MAP4K3-ZEB1-PLGF signaling axis and controls brown adipose tissue angiogenesis and insulin resistance.
    Becker-Greene D; Li H; Perez-Cremades D; Wu W; Bestepe F; Ozdemir D; Niosi CE; Aydogan C; Orgill DP; Feinberg MW; Icli B
    Cell Mol Life Sci; 2021 Dec; 78(23):7663-7679. PubMed ID: 34698882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer.
    Garan LAW; Xiao Y; Lin WC
    Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2209211119. PubMed ID: 36252018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.